Device Trial Radar · NCT03016754
Heart Failure Optimization Study
Last checked: Nov 19, 2026Latest source record: Mar 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
602
Actual
Start
Mar 1, 2017
Primary completion
Jun 1, 2022
Study completion Jun 1, 2022
Sponsor
- Lead sponsor
- Zoll Medical CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 11, 2017
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed as a multi-center prospective observational study of newly diagnosed Heart Failure (HF) patients to test the hypothesis that additional Ejection Fraction (EF) recovery occurs between 90 and 180 days as Guideline Directed Medical Therapy (GDMT) is achieved. Although the study doesn't start until day 90, all eligible, consenting patients will be entered into a registry at the start of wearable cardioverter defibrillator (WCD) use. The pre-study registry will allow us to collect early (90 day) outcomes and data in those patients who are likely to be eligible for the study at day 90, or are eligible, but refuse the study at day 90.
Conditions
- Sudden Cardiac Death
- Sudden Cardiac Arrest
- Heart Failure
- Heart Failure Low Output
Interventions
Wearable Cardioverter DefibrillatorDevice
LifeVest is the brand of Wearable Cardioverter Defibrillator used in this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients With LVEF Recovery at Day 90 and 180Time frame: 180 days
- Percentage of Study Subjects Reaching Target Doses of Guideline Directed Medical Therapy (GDMT)Time frame: 180 days
Locations
67 sites in 4 countries. Site status is shown where the registry gives one.
UAB Division of Cardiovascular Disease
Birmingham, Alabama
Study Site
West Hills, California
Baptist Heart Specialists
Fernandina Beach, Florida
64 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.